Hot Features
Premium
Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 5,644,272 |
|
|||||
| News | - | ||||||
| Day High | 6.56 | Low High |
|||||
| Day Low | 6.27 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Ardelyx Inc | ARDX | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.10 | 1.55% | 6.54 | 19:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 6.39 | 6.27 | 6.56 | 6.48 | 6.44 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 28,032 | 5,644,272 | US$ 6.39 | US$ 36,075,051 | - | 3.16 - 10.13 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:57:44 | 20 | US$ 6.64 | USD |
Ardelyx (ARDX) Options Flow Summary
Ardelyx Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 1.51B | 232.69M | - | 124.46M | -66.07M | -0.28 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ardelyx News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ARDX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.27 | 7.43 | 6.27 | 6.73 | 4,250,303 | -0.73 | -10.04% |
| 1 Month | 7.77 | 7.89 | 6.27 | 7.22 | 5,039,763 | -1.23 | -15.83% |
| 3 Months | 8.90 | 10.13 | 6.27 | 8.39 | 5,555,179 | -2.36 | -26.52% |
| 6 Months | 3.83 | 10.13 | 3.40 | 6.97 | 5,969,583 | 2.71 | 70.76% |
| 1 Year | 4.82 | 10.13 | 3.16 | 5.49 | 5,858,407 | 1.72 | 35.68% |
| 3 Years | 8.80 | 10.13 | 0.4902 | 3.02 | 6,797,470 | -2.26 | -25.68% |
| 5 Years | 3.40 | 10.4343 | 0.4902 | 3.27 | 4,370,294 | 3.14 | 92.35% |
Ardelyx Description
| Ardelyx Inc is a biotechnology company focused on the discovery, development, and commercialization of molecule and polymeric therapeutics to treat the gastrointestinal tract and cardiorenal diseases. The company has a proprietary drug discovery and design platform. Its lead product candidate is tenapanor, which aims to reduce the absorption of dietary sodium and phosphorus for the treatment of kidney disease, irritable bowel syndrome with constipation, and hyperphosphatemia in patients with dialysis. |
